Article

Rite Aid to Release Second Quarter Results on September 18

PRESS RELEASE

CAMP HILL, Pa. (Sept. 5, 2014) - Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2015 Second Quarter, which ended Aug. 30, 2014, on Thursday, Sept. 18, 2014. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet and can be accessed through the websites www.riteaid.com and www.StreetEvents.com

.

A playback of the call will be available on the Internet at www.riteaid.com

and

www.StreetEvents.com starting at 12 p.m. Eastern Time Thursday, September 18. The playback will be available on both sites until the company's next conference call.

A playback of the call will also be available by telephone beginning at 12 p.m. Eastern Time on Sept. 18, 2014 and ending at 11:59 p.m. Eastern Time on Sept. 20, 2014. The playback number is (855) 859-2056 from within the U.S. and Canada or (404) 537-3406 from outside the U.S. and Canada with the eight-digit reservation number 96416227.

Rite Aid Corporation is one of the nation's leading drugstore chains with nearly 4,600 stores in 31 states and the District of Columbia and fiscal 2014 annual revenues of $25.5 billion. Information about Rite Aid, including corporate background and press releases, is available through the company's website at www.riteaid.com.

###

Contact:

Investors:

Matt Schroeder 717-214-8867

or

investor@riteaid.com

Media:

Susan Henderson 717-730-7766

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com